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Introduction
Acute mesenteric ischemia (AMI) is a life threatening dis-
ease and one of the emergency surgery conditions (1). A 
gradual obstruction, known as chronic mesenteric isch-
emia does not cause a serious problem because of forma-
tion of collateral vessels. However, an acute obstruction of 
either main mesenteric arteries or even one of the branch-
es causes severe symptoms and needs early intervention 
(2). Four causes of abdominal ischemia exist including: 1) 
acute mesenteric arterial embolism, 2) acute mesenteric 
arterial thrombosis, 3) non-occlusive mesenteric isch-
emia (systemic hypoperfusion from cardiac failure, sepsis, 
medications), and 4) mesenteric venous thrombosis (3). 
Regardless of pathophysiologic cause, AMI leads to the 
intestinal mucosa flaking after 3 hours of start and whole 
intestinal thickness infarction after 6 hours and finally 
perforation and peritonitis (2). Clinically, the most com-
mon symptom remains a severe abdominal pain that is 
not proportional to the amount of tenderness. This pain 
is typically in colic form and localized in umbilical region. 
There may be other associated symptoms like nausea, 
vomiting, and diarrhea. Physical exam in early stage only 
reveals a mild tenderness (3). Early diagnosis of this con-
dition is difficult. Procedures like plain abdominal x-ray, 
abdominal ultrasonography, and computed tomography 
(CT) scan are performed to rule out the other differential 
diagnosis and are often normal especially in early stages. 
In patients with unstable hemodynamic and peritonitis 
symptoms, the first procedure is emergency laparotomy 
(1,2). Angiography of mesenteric arteries is the most reli-
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Abstract
Objective: Acute mesenteric ischemia (IMA) is a vascular emergency with broad variability 
of clinical presentations and non-specific laboratory findings. Therefore, there is a 
significant need for reliable serological markers of ischemia. Various laboratory studies 
may be performed for suspected AMI, but in general, such studies will not establish the 
diagnosis.
Methods: In a prospective, non-interventional study, from October 2012 to October 
2013, we investigated 70 patients with probable diagnosis of AMI. Blood samples were 
taken from patients and analyzed for complete blood count (CBC), prothrombin time (PT), 
partial thromboplastin time (PTT), international normalized ratio (INR), urea, creatinine 
(Cr), sodium (Na), potassium (K), D-dimer, lactate, amylase, PH, partial pressure of carbon 
dioxide (PCO2), and bicarbonate (HCO3). Finally the results were compared with AMI 
diagnosis confirmed by computed tomography (CT) angiography.
Results: Seventy patients with acute severe abdominal pain were studied. Thirty-nine 
patients (55.7%) were male and 31 patients (44.3%) were female. The average age was 
68.01 ± 14.67 (±SD). Based on CT-angiography results, 27 (38.6%) patients had AMI and 
43 (61.4%) patients did not have AMI. Chi-squire test showed P values of 0.606 and 
0.986 for relations between sex and risk factors with AMI correspondingly. One-sample 
Kolmogorov-Smirnov revealed white blood cell (WBC), hemoglobin (Hb), platelets (Plt), 
urea, Cr, Na, K, PCO2 and HCO3 as normally distributed parameters (P > 0.05). Moreover PT, 
PTT, INR, D-dimer, lactate, amylase, and PH were non-normally distributed (P < 0.05). 
Conclusion: We found a significant relation between increased serum lactate level and 
definitive AMI diagnosis. We recommend rising serum lactate as a finding in AMI. 
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able diagnostic method with the sensitivity of 74%-100% 
and specificity of 100%. Because of difficult access, high 
costs and wasting time in this method, researchers try 
to find a laboratory method for early diagnosis of AMI 
(4). Delayed lab findings include: leukocytosis, acidosis, 
increased amylase, and increased creatinine kinase (BB 
isoenzyme). Normal serum level of leukocyte and D-di-
mer in primary phase rules out AMI diagnosis (5). Due 
to the broad variability of clinical presentations and non-
specific laboratory findings the mortality of this condition 
remains high, thus there is a significant need for reliable 
and enhanced serological markers of intestinal ischemia. 
Several studies have shown the role of different serum bio-
markers in early diagnosis of AMI but none of them is suf-
ficiently accurate and singly reliable (6). 
Methods
In a prospective, non-interventional study that was con-
ducted in the emergency department of Imam Reza hos-
pital, Tabriz, Iran, from October 2012 to October 2013, we 
investigated 70 patients with probable diagnosis of AMI. 
All patients with a severe abdominal pain, which was dis-
proportionate with tenderness and one of the AMI risk 
factors such as: atrial fibrillation, hear failure, ischemic 
heart disease, hypertension and diabetes were included 
(7). Blood samples were taken from patients and analyzed 
for complete blood count (CBC), prothrombin time (PT), 
partial thromboplastin time (PTT), international normal-
ized ratio (INR), urea, creatinine (Cr), sodium (Na), po-
tassium (K), D-dimer, lactate, amylase, PH, partial pres-
sure of carbon dioxide (PCO2), and bicarbonate (HCO3). 
Patients with high possibility conditions of rising D-dimer 
were excluded (recent history of surgery, trauma, preg-
nancy, deep vein thrombosis [DVT], etc.). No interven-
tion was done in the course of routine diagnosis and treat-
ment of patients in emergency department. Finally an ex-
Table 1. Frequencies of patients’ risk factors
Risk factors
DM AF HF HTN IHD
AMI  
No. 12 9 7 13 9
% 17.1 12.85 10.0 18.5 12.9
N ot AMI
No. 21 16 14 20 13
% 30.0 22.85 20.0 28.6 18.5
 Total
No. 33 25 21 33 22
% 47.1 35.7 30.0 47.1 31.4
Table 2. Results of independent t test
WBC Hb Plt Urea Cr Na K PCO2 HCO3
P value 0.87 0.69 0.61 0.53 0.19 0.91 0.70 0.74 0.16
Table 3. Results of Mann-Whitney U test
Parameters
PT PTT INR D-dimer Lactate Amylase PH
P value 0.132 0.066 0.094 0.256 0.006 0.465 0.781
act diagnosis was obtained according to CT-angiography 
findings and compared with lab results.
We entered all collected data in this study into SPSS (ver-
sion 15.0; SPSS, Chicago, Ill) software. We used descrip-
tive statics to analyze sex, age, results of CT scan, risk fac-
tors and lab findings.
We used chi-squire method to analyze the relationship 
between risk factors and gender with CT-angiography re-
sults. We used one-sample Kolmogorov-Smirnov test to 
evaluate whether the data were normally distributed or 
not. Independent t test was used to analyze the normally 
distributed date. Moreover, Mann-Whitney U test was 
used to analyze non-normally distributed data. P values 
<0.05 were considered statistically significant.
Results
In this study, 70 patients were suspected AMI. The results 
were as follows: Among them, 39 patients (55.7%) were 
male and 31 patients (44.3%) were female. The average 
age was 68.01 ± 14.67 (±SD). Based on CT-angiography 
results, 27 (38.6%) patients had AMI and 43 (61.4%) pa-
tients did not have AMI.
Chi-squire test showed P values of 0.606 and 0.986 for re-
lations between sex and risk factors with AMI correspond-
ingly. Frequencies of risk factors are shown in Table 1. 
The mean white blood cell (WBC), hemoglobin (Hb), 
platelets (Plt), PT, PTT, INR, urea, Cr, Na, K, D-dimer, lac-
tate, amylase, PH, PCO2, HCO3 were 11.66 ± 6.61 (±SD), 
12.63 ± 3.08 (±SD), 244.66 ± 119.40 (±SD), 15.13 ± 4.89 
(±SD), 36.39 ± 8.90 (±SD), 1.44 ± 1.16 (±SD), 55.99 ± 33.38 
(±SD), 1.24 ± 0.36 (±SD), 139.04 ± 4.28 (±SD), 0.75±1.15 
(±SD), 27.55 ± 13.24 (±SD), 102.35 ± 302.09 (±SD), 
7.31 ± 0.33 (±SD), 36.05 ± 9.40 (±SD), 20.33 ± 5.26 (±SD) 
respectively.
One-sample Kolmogorov-Smirnov revealed WBC, Hb, 
Plt, urea, Cr, Na, K, PCO2 and HCO3 as normally dis-
tributed parameters (P > 0.05). Moreover, PT, PTT, INR, 
D-dimer, lactate, amylase and PH were non-normally dis-
tributed (P < 0.05). Independent t test results are shown in 
Table 2.
The mean ranks of PT, PTT, INR, D-dimer, lactate, amy-
lase and PH in patients with and without AMI were 39.94 
and 32.71, 41.09 and 31.99, 40.39 and 32.43, 38.96 and 
33.33, 43.93 and 30.21, 33.26 and 36.53, 34.65 and 36.03 
respectively. The results of Mann-Whitney U test is shown 
in Table 3.
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Discussion
There was no significant relationship between risk factors 
and gender with AMI. We could not observe any signifi-
cant relationship between normally distributed data and 
AMI (P > 0.05). Serum lactate levels in patients with AMI 
(mean rank: 43.93) were significantly higher than patients 
without AMI (mean rank: 30.21) (P = 0.006).
Serum lactate has repeatedly been assumed to be the best 
marker of AMI. However, numerous studies have proved 
that it is only an unspecific marker of tissue hypo perfu-
sion and does not confirm AMI diagnosis. A review study 
by Demir et al has completely evaluated the role for serum 
lactate measurement in diagnosing AMI. They discovered 
that despite the emphasis of many studies on lactate in-
creased in AMI, the level of no single serum marker, in-
cluding serum lactate, is elevated early and specifically 
enough in the serum to diagnose AMI (8). In some similar 
studies with close results to current data, serum lactate as 
a marker of cell hypoxia has been shown to have a high 
sensitivity of (96% or 78%) in patients with mesenteric 
ischemia (9,10). On the other hand, low lactate levels may 
help in ruling out the diagnosis of intestinal ischemia and 
avoid unnecessary laparotomies (11-13). A study on a pig 
that his superior mesenteric artery was surgically ligated 
revealed that peripheral blood tests do not enable the de-
tection of mesenteric ischemia within 4 hours after onset 
and during this time lactate changes only appear in su-
perior mesenteric vein (14). Aydin et al in a research on 
rats with superior mesenteric artery occlusion measured 
serum lactate and D-dimer. They found that blood L-lac-
tate levels began to increase significantly following forth 
hour of mesenteric ischemia so it seems to be a suitable 
marker to use in emergency departments for early AMI 
diagnosis. Conversely about D-dimer, it was revealed that 
mesenteric ischemia does not cause significantly D-dimer 
increase and it is not a useful marker for early diagnosis 
of AMI (15).
We reached the same consequence about D-dimer. In a 
recent study, D-dimer did not have a significant difference 
between AMI and non-AMI patients so as for recent data 
it is not an appropriate marker to decide about AMI. A 
prospective study on 67 patients with clinical suspicion 
of AMI showed that detection of serum D-dimer cannot 
help to differentiate patients with AMI from those with 
non-AMI and there is no correlation between serum D-
dimer levels and the severity of AMI (16). Kulacoglu et 
al studied on rats, their data did not support the use of 
blood D-dimer level as an independent parameter in the 
diagnosis of mesenteric ischemia due to arterial throm-
bosis (17). Clot fibrinolysis process in blood produces 
D-dimer from fibrin degradation. Therefore, D-dimer 
does not normally exist in plasma and it is created when 
coagulation system becomes activated. Negative result of 
D-dimer rules out thrombosis. False positive results oc-
cur in liver disease, high rheumatoid factor, inflamma-
tion, malignancy, trauma, pregnancy and recent surgery 
(18,19). According to the role of plasma, D-dimer to de-
tect thrombosis, in contrast to our data, numerous studies 
confirmed D-dimer as an early diagnostic factor for AMI 
(20-22). Abd-Elazeem and Selim evaluated D-dimer in 
AMI patients. They concluded that plasma D-dimer >3.8 
ug/ml combined with relevant clinical variables has a high 
positive predictive value for early identification of patients 
with AMI and plasma D-dimer <0.53 ug/ml has a high 
negative predictive value for AMI and can be used as an 
exclusion test. So D-dimer testing should be performed in 
patients with acute abdomen (23). Another study on pa-
tients with a clinical suspicion of AMI estimated the sen-
sitivity (94.7%) and specificity (78.6%) of D-dimer testing 
for the diagnosis of AMI and mentioned it as a marker for 
early diagnosis in patients for whom we cannot use CT 
angiography (24).
Amylase and acidosis stand two other markers that are 
recommended to be measured in diagnostic process of 
AMI. Elevated levels of amylase and also acidosis in the 
blood are two non-specific indicators of mesenteric isch-
emia (2,3). In the current study, we did not find any sig-
nificant difference between AMI and non-AMI patients in 
rising serum amylase and acidosis. So, we do not suggest 
amylase and acidosis as factors to decide about AMI. In 
the current study, we just found serum lactate rising in pa-
tients with AMI and none of the other investigated factors 
showed a significant correlation.
Limitations
This study was carried out in one referral center and also 
with a small study group. Larger study samples are needed 
to promote the accuracy of our findings. 
Conclusion
No serum marker is sensitive or specific enough to estab-
lish or exclude the diagnosis of AMI. We found a signifi-
cant relation between increased serum lactate level and 
definitive AMI diagnosis. We recommend rising serum 
lactate as a finding in AMI. 
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